Press release
Neurofibromatosis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Novartis, AstraZeneca, Merck Sharp & Dohme LLC, SpringWorks Therapeutics, NFlection Therapeutics, Inc.
To Know in detail about the Neurofibromatosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Neurofibromatosis Market Forecast
https://www.delveinsight.com/sample-request/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Neurofibromatosis Market Report:
• The Neurofibromatosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to DelveInsight's projections, there will be 10,508 diagnosed prevalent cases of NF-2 in the US alone in 2022, out of a total of 16,874 cases globally. This number of cases is anticipated to increase between 2019 and 2032
• Approximately 96% of cases of neurofibromatosis, according to Le et al. (2022), are type 1.One in every 3000 newborns is affected. Both racial and gender differences are present. Half of the patients have a hereditary mutation, while the other half have a spontaneous mutation. The prevalence of neurofibromatosis type 2 ranges from 1 in 33,000 births to 1 in 87,410, accounting for around 3% of all cases
• A large number of pharmaceutical companies are entering this illness area as a result of scientific advancements. NFX-179 Gel, Mirdametinib, and FCN-159 are a few new medications
• Key Neurofibromatosis Companies: Fosun Pharmaceutical, SpringWorks Therapeutics, NFlection Therapeutics, Inc., Shanghai Kechow Pharma, Novartis, Merck Sharp & Dohme LLC, SpringWorks Therapeutics, NFlection Therapeutics, Inc., AstraZeneca, Array BioPharma, Recursion Pharmaceuticals, and others
• Key Neurofibromatosis Therapies: FCN-159, NFX-179 Gel, HL-085, RAD001:Everolimus:, Selumetinib granule formulation, Mirdametinib (PD-0325901), NFX-179, Selumetinib, Trametinib, Binimetinib, REC-2282, AZD2014, and others
• The Neurofibromatosis epidemiology based on type-specific cases analyzed that Prevalent Cases of Neurofibromatosis is highest for NF1
• The Neurofibromatosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neurofibromatosis pipeline products will significantly revolutionize the Neurofibromatosis market dynamics.
Neurofibromatosis Overview
Neurofibromatosis is a genetic disorder characterized by the growth of noncancerous tumors on nerves throughout the body. It is caused by mutations in specific genes that affect nerve cell growth and development.
Get a Free sample for the Neurofibromatosis Market Report
https://www.delveinsight.com/report-store/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Neurofibromatosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Neurofibromatosis Epidemiology Segmentation:
The Neurofibromatosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Neurofibromatosis
• Prevalent Cases of Neurofibromatosis by severity
• Gender-specific Prevalence of Neurofibromatosis
• Diagnosed Cases of Episodic and Chronic Neurofibromatosis
Download the report to understand which factors are driving Neurofibromatosis epidemiology trends @ Neurofibromatosis Epidemiology Forecast
https://www.delveinsight.com/sample-request/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Neurofibromatosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Neurofibromatosis market or expected to get launched during the study period. The analysis covers Neurofibromatosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Neurofibromatosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Neurofibromatosis Therapies and Key Companies
• FCN-159: Fosun Pharmaceutical
• NFX-179 Gel: NFlection Therapeutics, Inc.
• HL-085: Shanghai Kechow Pharma
• RAD001:Everolimus: Novartis
• Selumetinib granule formulation: Merck Sharp & Dohme LLC
• Mirdametinib (PD-0325901): SpringWorks Therapeutics
• NFX-179: NFlection Therapeutics, Inc.
• Selumetinib: AstraZeneca
• Trametinib: Novartis
• Binimetinib: Array BioPharma
• REC-2282: Recursion Pharmaceuticals
• AZD2014: AstraZeneca
Discover more about therapies set to grab major Neurofibromatosis market share @ Neurofibromatosis Treatment Market
https://www.delveinsight.com/sample-request/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Neurofibromatosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Neurofibromatosis Companies: Fosun Pharmaceutical, SpringWorks Therapeutics, NFlection Therapeutics, Inc., Shanghai Kechow Pharma, Novartis, Merck Sharp & Dohme LLC, SpringWorks Therapeutics, NFlection Therapeutics, Inc., AstraZeneca, Array BioPharma, Recursion Pharmaceuticals, and others
• Key Neurofibromatosis Therapies: FCN-159, NFX-179 Gel, HL-085, RAD001:Everolimus:, Selumetinib granule formulation, Mirdametinib (PD-0325901), NFX-179, Selumetinib, Trametinib, Binimetinib, REC-2282, AZD2014, and others
• Neurofibromatosis Therapeutic Assessment: Neurofibromatosis current marketed and Neurofibromatosis emerging therapies
• Neurofibromatosis Market Dynamics: Neurofibromatosis market drivers and Neurofibromatosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Neurofibromatosis Unmet Needs, KOL's views, Analyst's views, Neurofibromatosis Market Access and Reimbursement
To know more about Neurofibromatosis companies working in the treatment market, visit @ Neurofibromatosis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Neurofibromatosis Market Report Introduction
2. Executive Summary for Neurofibromatosis
3. SWOT analysis of Neurofibromatosis
4. Neurofibromatosis Patient Share (%) Overview at a Glance
5. Neurofibromatosis Market Overview at a Glance
6. Neurofibromatosis Disease Background and Overview
7. Neurofibromatosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Neurofibromatosis
9. Neurofibromatosis Current Treatment and Medical Practices
10. Neurofibromatosis Unmet Needs
11. Neurofibromatosis Emerging Therapies
12. Neurofibromatosis Market Outlook
13. Country-Wise Neurofibromatosis Market Analysis (2019-2032)
14. Neurofibromatosis Market Access and Reimbursement of Therapies
15. Neurofibromatosis Market Drivers
16. Neurofibromatosis Market Barriers
17. Neurofibromatosis Appendix
18. Neurofibromatosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Neurofibromatosis Pipeline https://www.delveinsight.com/report-store/neurofibromatosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Neurofibromatosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Neurofibromatosis market. A detailed picture of the Neurofibromatosis pipeline landscape is provided, which includes the disease overview and Neurofibromatosis treatment guidelines.
Neurofibromatosis Epidemiology https://www.delveinsight.com/report-store/neurofibromatosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Neurofibromatosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Neurofibromatosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market
DelveInsight's "Idiopathic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Idiopathic Thrombocytopenic Purpura, historical and forecasted epidemiology as well as the Idiopathic Thrombocytopenic Purpura market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market
DelveInsight's "Inguinal Hernia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Inguinal Hernia, historical and forecasted epidemiology as well as the Inguinal Hernia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Charcot-marie-tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
DelveInsight's 'Charcot-Marie-Tooth Disease Market Insights, Epidemiology, and Market Forecast 2032' report deliver an in-depth understanding of the Charcot-Marie-Tooth Disease, historical and forecasted epidemiology as well as the Charcot-Marie-Tooth Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.
Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
DelveInsight's "Dysfunctional Uterine Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dysfunctional Uterine Bleeding, historical and forecasted epidemiology as well as the Dysfunctional Uterine Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Mrna Based Vaccines And Therapeutics Market
https://www.delveinsight.com/report-store/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market
DelveInsight's "Global Messenger RNA (mRNA)-based Vaccines and Therapeutics- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics, historical and forecasted epidemiology as well as the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Papilloma Market
https://www.delveinsight.com/report-store/papilloma-market
DelveInsight's "Papilloma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Papilloma, historical and forecasted epidemiology as well as the Papilloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market
DelveInsight's "Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurofibromatosis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Novartis, AstraZeneca, Merck Sharp & Dohme LLC, SpringWorks Therapeutics, NFlection Therapeutics, Inc. here
News-ID: 3633357 • Views: …
More Releases from DelveIinsight Business Research
Advanced Renal Cell Carcinoma Market Report 2034: Epidemiology Data, Therapies, …
DelveInsight's "Advanced Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as well as the Antibody Drug Conjugates market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Advanced Renal Cell Carcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Advanced Renal…
PCSK9 Inhibitors Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PCSK9 Inhibitors pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"PCSK9 Inhibitors Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PCSK9 Inhibitors Market.
The PCSK9…
Metastatic Prostate Cancer Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Prostate Cancer pipeline constitutes 75+ key companies continuously working towards developing 75+ Metastatic Prostate Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Metastatic Prostate Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Metastatic Prostate…
Bunion (Hallux Valgus) Market to Expand Significantly by 2034, States DelveInsig …
DelveInsight's "Bunion Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the Bunion market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Bunion market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bunion Market Forecast
https://www.delveinsight.com/sample-request/hallux-valgus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Bunion…
More Releases for Neurofibromatosis
Neurofibromatosis Market Dynamics Indicate Upward Trajectory Through 2032, Repor …
DelveInsight's "Neurofibromatosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Neurofibromatosis, historical and forecasted epidemiology as well as the Neurofibromatosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Neurofibromatosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Neurofibromatosis Market Forecast
https://www.delveinsight.com/sample-request/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Neurofibromatosis…
Neurofibromatosis Type-1 Market Is Booming Worldwide - AstraZeneca, GlaxoSmithKl …
Neurofibromatosis Type-1 Market Insights
The Neurofibromatosis Type-1 Market is projected to reach USD 2.4 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).
Coherent Market Insights has published a new comprehensive analysis on the Neurofibromatosis Type-1 Market (2025-2032), focusing on critical transformations in the U.S. healthcare environment. This report highlights essential metrics including market size, revenue forecasts, CAGR, adoption trends, and regulatory drivers. Backed by clinical evidence…
Neurofibromatosis Treatment Market Size, Industry And Forecast To 2033
The new report published by The Business Research Company, titled Neurofibromatosis Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the neurofibromatosis treatment market size has grown rapidly in recent years. It will grow from $11.41 billion in 2023…
Neurofibromatosis Treatment Market Research Analysis, Application And Forecast T …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Neurofibromatosis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $21.58 billion In 2028 At…
Neurofibromatosis Type-2 Market Insight, Epidemiology and Market Forecast - 2027
Neurofibromatosis Type-2 Market research report is the new statistical data source added by Infinity Business Insights.
The genetic disease neurofibromatosis type 2 (NF2) is most often linked with bilateral vestibular schwannomas, also known as auditory neuromas. These benign (noncancerous) tumours develop on the balance and hearing nerves that go to the inner ear. Although benign, these tumours can cause hearing and balance issues. People with NF2 are also more likely…
Neurofibromatosis Treatment Market to Set Phenomenal Growth by 2023
Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue. These formed tumors may develop anywhere in the nervous system of the victim, which may include the brain, spinal cord and nerves. Neurofibromatosis is usually diagnosed in childhood or early adulthood. The tumors are noncancerous (benign) in most of the cases, but in some cases these tumors become cancerous…
